医学
安慰剂
随机对照试验
维生素
不利影响
维生素D与神经学
哮喘
维生素D缺乏
胃肠病学
子群分析
内科学
置信区间
替代医学
病理
作者
Kana Ram Jat,Nancy Goel,Nandita Gupta,Chandra Prakash Gupta,Sudip Kumar Datta,Rakesh Lodha,Sushil Kumar Kabra
摘要
Abstract Background Vitamin D supplementations for asthma control had shown inconsistent results. We aimed to study efficacy and safety of vitamin D supplementation in asthmatic children who were vitamin D deficient. Methods This double‐blind, randomized controlled trial enrolled asthmatic children of 4‐12 years of age who had 25‐hydroxyvitamin D [25(OH)D] levels <20 ng/mL. The participants were randomized to receive either vitamin D orally 1000 IU/d for 9 months or similar‐looking placebo. The primary outcomes were the proportion of children having the Childhood Asthma Control Test (CACT) score of ≥20 at the end of the treatment and adverse effects. Results The trial included 250 children (125 in each group) with a mean age of 8.1 ± 2.3 years and 180 boys. The baseline parameters were similar between the groups, including CACT score (21.7 ± 4.2 vs 21.9 ± 3.6, vitamin D vs placebo). At the end of the study, the proportion of asthmatic children who had CACT score ≥ 20 was similar between vitamin D and placebo group (93.6% vs 92.0%, P = .625). The number of exacerbations of asthma and side effect profile was also identical between the groups. 25(OH)D levels increased significantly in the vitamin D group (18.06 ± 7.11 vs 12.03 ± 5.98 ng/mL, P < .001). The results did not change when we did subgroup analysis for children with baseline CACT score < 20 and 25(OH)D levels at the end of the study ≥20 ng/mL. Conclusion Vitamin D supplementation in asthmatic children with vitamin D deficiency did not improve control of asthma.
科研通智能强力驱动
Strongly Powered by AbleSci AI